IRON
Disc Medicine Inc.
NASDAQ: IRON · HEALTHCARE · BIOTECHNOLOGY
$65.97
-1.92% today
Updated 2026-04-29
Market cap
$2.52B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.01
Dividend yield
—
52W range
$40 – $100
Volume
0.5M
Disc Medicine Inc. (IRON) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-32.71M | $-27.53M | $-42.25M | $-73.46M | $-93.93M | $-180.39M |
| Capital expenditures | $22000.00 | $68000.00 | $151000.00 | $89000.00 | $505000.00 | $933000.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $983000.00 | $507000.00 | $2.09M | $5.53M | $16.82M | $34.34M |
| Free cash flow | $-32.73M | $-27.60M | $-42.40M | $-73.55M | $-94.43M | $-181.33M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |